Ligands

Details for Australian Patent Application No. 2009200802 (hide)

Owner AstraZeneca AB

Inventors Heys, John Richard; McCarthy, Dennis J.; Keith, Richard A.; Phillips, Eifion; Smith, Mark A.; Dorff, Peter; Gordon, John

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009200802

Parent 2004276061

Filing date 27 February 2009

Wipo publication date 19 March 2009

International Classifications

A61K 31/438 (2006.01) - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 491/22 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

12 March 2009 Complete Application Filed

19 March 2009 Application Open to Public Inspection

  Published as AU-A-2009200802

21 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009200803-Aptamer-nanoparticle conjugates and method of use for target analyte detection

2009200801-Use of ginseng fractions for preventing or reducing hematological malignancies